The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Loan Stock

22 Dec 2017 12:37

RNS Number : 2584A
Sopheon PLC
22 December 2017
 

 

SOPHEON PLC

("Sopheon", the "Company" or the "Group")

 

CONVERSION OF LOAN STOCK

PDMR SHAREHOLDING

 

Further to the announcement made on 8 December 2017, the Company is pleased to announce that at the meeting of the Loan Stock holders held earlier today the proposed changes to the terms of the Loan Stock were formally approved. Application has been made for 2,535,947 new ordinary shares of 20p each in the Company ("Ordinary Shares") to be admitted to trading on AIM, and dealings are expected to commence on 28 December 2017.

 

The following Directors converted Loan Stock and their resultant holdings are as follows:

 

Ordinary Shares issued pursuant to the conversion of Loan Stock

Total Beneficial interest in Ordinary Shares

% of issued share capital

Barry Mence*

836,601

2,289,177

22.9%

Andrew Michuda 

58,823

88,823

0.9%

Arif Karimjee*

35,294

85,294

0.9%

Stuart Silcock** 

261,437

538,564

5.4%

 

 

\* Total beneficial interest in Ordinary Shares, including those held by his wife

 

*\* Total beneficial interest in Ordinary Shares, including those of his wife, as well as his interest in Ordinary Shares held in Bare Trust for his grandchildren

 

The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The Company's issued share capital now consists of 9,999,378 Ordinary Shares. Accordingly, the figure of 9,999,378 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information contact:

Barry Mence, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (corporate finance)

Mia Gardener (corporate broking)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete Enterprise Innovation Management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Barry Mence

2.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 20p

Identification code

GB00BSZM1369

b)

Nature of the transaction

Conversion of loan stock

c)

Price(s) and volume(s)

 

 

 

Director

Price(s)

Volume(s)

Barry Mence

76.5p

836,601

 

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As per 4(c) above

e)

Date of the transaction

22 December 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

5.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Michuda 

6.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

7.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

8.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 20p

Identification code

GB00BSZM1369

b)

Nature of the transaction

Conversion of loan stock

c)

Price(s) and volume(s)

 

 

 

Director

Price(s)

Volume(s)

Andrew Michuda

76.5p

58,823

 

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As per 4(c) above

e)

Date of the transaction

22 December 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

9.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Stuart Silcock 

10.

Reason for the Notification

a)

Position/status

PDMR

b)

Initial notification/Amendment

Initial notification

11.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

12.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 20p

Identification code

GB00BSZM1369

b)

Nature of the transaction

Conversion of loan stock

c)

Price(s) and volume(s)

 

 

 

Director

Price(s)

Volume(s)

Stuart Silcock

76.5p

261,437

 

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As per 4(c) above

e)

Date of the transaction

22 December 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

13.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Fiona Karimjee

14.

Reason for the Notification

a)

Position/status

PCA of PDMR

b)

Initial notification/Amendment

Initial notification

15.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Sopheon plc

b)

LEI

213800TA9E6UG2WWG646

16.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 20p

Identification code

GB00BSZM1369

b)

Nature of the transaction

Conversion of loan stock

c)

Price(s) and volume(s)

 

 

 

PCA

Price(s)

Volume(s)

Fiona Karimjee

76.5p

35,294

 

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As per 4(c) above

e)

Date of the transaction

22 December 2017

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLLFLDLFXFBX
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.